Works by Shah, Nirav N.
Results: 44
Correction: Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 12, p. 1, doi. 10.1038/s41408-019-0261-1
- By:
- Publication type:
- Article
Phase I/II trial of bendamustine, ixazomib, and dexamethasone in relapsed/refractory multiple myeloma.
- Published in:
- Blood Cancer Journal, 2019, v. 9, n. 8, p. N.PAG, doi. 10.1038/s41408-019-0219-3
- By:
- Publication type:
- Article
Multi Targeted CAR-T Cell Therapies for B-Cell Malignancies.
- Published in:
- Frontiers in Oncology, 2019, p. N.PAG, doi. 10.3389/fonc.2019.00146
- By:
- Publication type:
- Article
Immunoglobulin High Throughput Sequencing (Ig-HTS) Minimal Residual Disease (MRD) Analysis is an Effective Surveillance Tool in Patients With Mantle Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 4, p. 254, doi. 10.1016/j.clml.2023.12.006
- By:
- Publication type:
- Article
Impact of Chronic Kidney Disease and Acute Kidney Injury on Safety and Outcomes of CAR T-Cell Therapy in Lymphoma Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 11, p. 863, doi. 10.1016/j.clml.2022.07.007
- By:
- Publication type:
- Article
Shorter Interval between Treatment and COVID Immunization Is Associated With Poor Seroconversion in Patients with Hematological Malignancies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 7, p. e495, doi. 10.1016/j.clml.2022.01.010
- By:
- Publication type:
- Article
ABCL-040: Pirtobrutinib (LOXO-305), a Next-Generation, Highly Selective, Non-Covalent Bruton's Tyrosine Kinase Inhibitor in Previously Treated Mantle Cell Lymphoma and Other Non-Hodgkin Lymphomas: Phase 1/2 BRUIN Study Results.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S378, doi. 10.1016/S2152-2650(21)01863-2
- By:
- Publication type:
- Article
CLL-039: Pirtobrutinib (LOXO-305), a Next-Generation, Highly Selective, Non-Covalent BTK Inhibitor in Previously Treated CLL/SLL: Results from the Phase 1/2 BRUIN Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S315, doi. 10.1016/S2152-2650(21)01746-8
- By:
- Publication type:
- Article
Poster: ABCL-040: Pirtobrutinib (LOXO-305), a Next-Generation, Highly Selective, Non-Covalent Bruton's Tyrosine Kinase Inhibitor in Previously Treated Mantle Cell Lymphoma and Other Non-Hodgkin Lymphomas: Phase 1/2 BRUIN Study Results.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S241, doi. 10.1016/S2152-2650(21)01513-5
- By:
- Publication type:
- Article
Poster: CLL-039: Pirtobrutinib (LOXO-305), a Next-Generation, Highly Selective, Non-Covalent BTK Inhibitor in Previously Treated CLL/SLL: Results from the Phase 1/2 BRUIN Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S221, doi. 10.1016/S2152-2650(21)01392-6
- By:
- Publication type:
- Article
Oral Abstract: CLL-039: Pirtobrutinib (LOXO-305), a Next-Generation, Highly Selective, Non-Covalent BTK Inhibitor in Previously Treated CLL/SLL: Results from the Phase 1/2 BRUIN Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S202, doi. 10.1016/S2152-2650(21)01273-8
- By:
- Publication type:
- Article
Multicenter Analysis of Advanced Stage Grade 3A Follicular Lymphoma Outcomes by Frontline Treatment Regimen.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Extracavitary primary effusion lymphoma initially presenting with hemophagocytic lymphohistocytosis.
- Published in:
- 2014
- By:
- Publication type:
- journal article
Factors Associated With Unplanned 30-Day Readmissions After Hematopoietic Cell Transplantation Among US Hospitals.
- Published in:
- JAMA Network Open, 2019, v. 2, n. 7, p. e196476, doi. 10.1001/jamanetworkopen.2019.6476
- By:
- Publication type:
- Article
Outcomes of a hydroxyapatite ceramic-coated femoral stem in primary total hip arthroplasty: a report of excellent survivorship from a single United Kingdom centre.
- Published in:
- SICOT-J, 2024, v. 10, p. 1, doi. 10.1051/sicotj/2024026
- By:
- Publication type:
- Article
The role of FDG- PET imaging as a prognostic marker of outcome in primary mediastinal B-cell lymphoma.
- Published in:
- Cancer Medicine, 2015, v. 4, n. 1, p. 7, doi. 10.1002/cam4.322
- By:
- Publication type:
- Article
Outcomes of patients with secondary central nervous system lymphoma following CAR T-cell therapy: a multicenter cohort study.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01508-3
- By:
- Publication type:
- Article
What is the standard of care for primary mediastinal B cell lymphoma; R‐CHOP or DA‐EPOCH‐R? – Response to Melani et al.
- Published in:
- British Journal of Haematology, 2019, v. 184, n. 5, p. 838, doi. 10.1111/bjh.15183
- By:
- Publication type:
- Article
Graft‐versus‐host disease‐associated hepatic portal venous gas.
- Published in:
- 2018
- By:
- Publication type:
- Image
R‐CHOP <italic>versus</italic> dose‐adjusted R‐EPOCH in frontline management of primary mediastinal B‐cell lymphoma: a multi‐centre analysis.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 4, p. 534, doi. 10.1111/bjh.15051
- By:
- Publication type:
- Article
Bone Marrow Aplasia after CAR-T-Cell Therapy for Relapsed/Refractory Burkitt's Lymphoma.
- Published in:
- Medical Sciences, 2023, v. 11, n. 4, p. 67, doi. 10.3390/medsci11040067
- By:
- Publication type:
- Article
Extensive Surgical Wound Lavage Reduces the Incidence and Severity of Heterotopic Ossification in Primary Total Hip Replacement: A Study of 175 Hip Replacements.
- Published in:
- Hip & Pelvis, 2017, v. 29, n. 4, p. 234, doi. 10.5371/hp.2017.29.4.234
- By:
- Publication type:
- Article
Chimeric antigen receptor and bispecific T‐cell engager therapies in multiple myeloma patients with prior allogeneic transplantation.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 3, p. 887, doi. 10.1111/bjh.19244
- By:
- Publication type:
- Article
CAR T-cell therapy for B-cell lymphomas: outcomes and resistance mechanisms.
- Published in:
- Cancer & Metastasis Reviews, 2025, v. 44, n. 1, p. 1, doi. 10.1007/s10555-024-10228-0
- By:
- Publication type:
- Article
Chimeric antigen receptor modified T cell therapy in B cell non‐Hodgkin lymphomas.
- Published in:
- American Journal of Hematology, 2019, v. 94, p. S18, doi. 10.1002/ajh.25403
- By:
- Publication type:
- Article
Alpha-1-antitrypsin for the treatment of steroid-refractory acute gastrointestinal graft-versus-host disease.
- Published in:
- American Journal of Hematology, 2017, v. 92, n. 10, p. E610, doi. 10.1002/ajh.24850
- By:
- Publication type:
- Article
Extracavitary primary effusion lymphoma associated with hemophagocytic lymphohistiocytosis.
- Published in:
- American Journal of Hematology, 2016, v. 91, n. 11, p. 1161, doi. 10.1002/ajh.24475
- By:
- Publication type:
- Article
Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy.
- Published in:
- Blood & Lymphatic Cancer: Targets & Therapy, 2020, v. 10, p. 1, doi. 10.2147/BLCTT.S262592
- By:
- Publication type:
- Article
Mimicking Myelodysplastic Syndrome: Importance of Differential Diagnosis.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Lifitegrast ophthalmic solution for treatment of ocular chronic graft-versus-host disease.
- Published in:
- Leukemia & Lymphoma, 2020, v. 61, n. 4, p. 869, doi. 10.1080/10428194.2019.1695049
- By:
- Publication type:
- Article
The Role of Noncovalent BTK Inhibitors in the Era of Covalent BTK Inhibitors.
- Published in:
- Clinical Advances in Hematology & Oncology, 2024, v. 22, n. 3, p. 140
- By:
- Publication type:
- Article
Contemporary Outcomes for Advanced‐Stage Classical Hodgkin Lymphoma in the U.S.: Analysis of Surveillance, Epidemiology, and End Results Database.
- Published in:
- Oncologist, 2019, v. 24, n. 11, p. 1488, doi. 10.1634/theoncologist.2019-0172
- By:
- Publication type:
- Article
Outcomes and Toxicities of Programmed Death‐1 (PD‐1) Inhibitors in Hodgkin Lymphoma Patients in the United States: A Real‐World, Multicenter Retrospective Analysis.
- Published in:
- Oncologist, 2019, v. 24, n. 7, p. 955, doi. 10.1634/theoncologist.2018-0538
- By:
- Publication type:
- Article
Rare Germline Variants in Chordoma-Related Genes and Chordoma Susceptibility.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2704, doi. 10.3390/cancers13112704
- By:
- Publication type:
- Article
Bispecific Chimeric Antigen Receptor T Cell Therapy for B Cell Malignancies and Multiple Myeloma.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2523, doi. 10.3390/cancers12092523
- By:
- Publication type:
- Article
Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Pirtobrutinib, a highly selective, non-covalent (reversible) BTK inhibitor in previously treated CLL/SLL: updated results from the phase 1/2 BRUIN study.
- Published in:
- Acta Haematologica Polonica, 2022, v. 53, n. A, p. 33
- By:
- Publication type:
- Article
Gut microbiome and CAR-T therapy.
- Published in:
- Experimental Hematology & Oncology, 2019, v. 8, n. 1, p. N.PAG, doi. 10.1186/s40164-019-0155-8
- By:
- Publication type:
- Article
Incidence and characteristics of engraftment syndrome after autologous hematopoietic cell transplantation in light chain amyloidosis.
- Published in:
- Amyloid, 2019, v. 26, n. 4, p. 210, doi. 10.1080/13506129.2019.1645001
- By:
- Publication type:
- Article
Long‐term outcomes and predictors of early response, late relapse, and survival for patients treated with bispecific LV20.19 CAR T‐cells.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 12, p. 1580, doi. 10.1002/ajh.26718
- By:
- Publication type:
- Article
Leukemic phase and CSF involvement of diffuse large B‐cell lymphoma with a complex karyotype including a <italic>TP53</italic> deletion.
- Published in:
- Clinical Case Reports, 2018, v. 6, n. 1, p. 235, doi. 10.1002/ccr3.1250
- By:
- Publication type:
- Article
Design, Synthesis, and Anticancer Activity of 3H-benzo[f]chromen-3-one Derivatives.
- Published in:
- Journal of Heterocyclic Chemistry, 2017, v. 54, n. 4, p. 2501, doi. 10.1002/jhet.2853
- By:
- Publication type:
- Article